PRLD Financial Statements

Balance sheet, income statement, cash flow, and dividends for Prelude Therapeutics Inc (PRLD).


$70.17M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

PRLD Market Cap. (MRY)


PRLD Shares Outstanding (MRY)


PRLD Assets (MRY)


Total Assets

$175.51M

Total Liabilities

$44.06M

Total Investments

$121.14M

PRLD Income (MRY)


Revenue

$0

Net Income

-$127.17M

Operating Expense

$146.71M

PRLD Cash Flow (MRY)


CF Operations

-$102.89M

CF Investing

$90.19M

CF Financing

-$120.00K

PRLD Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PRLD Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$175,515,000 (-36.79%)

$277,665,000 (25.93%)

$220,500,000 (-27.73%)

$305,098,000 (36.45%)

Assets Current

$135,895,000 (-42.32%)

$235,589,000 (15.27%)

$204,380,000 (-30.75%)

$295,115,000 (33.65%)

Assets Non-Current

$39,620,000 (-5.84%)

$42,076,000 (161.02%)

$16,120,000 (61.47%)

$9,983,000 (258.97%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$131,459,000 (-44.55%)

$237,090,000 (21.31%)

$195,437,000 (-31.64%)

$285,897,000 (34.74%)

Property Plant & Equipment Net

$35,466,000 (-6.02%)

$37,737,000 (463.24%)

$6,700,000 (18.88%)

$5,636,000 (127.26%)

Cash & Equivalents

$16,518,000 (-43.69%)

$29,335,000 (-15.34%)

$34,649,000 (-3.41%)

$35,872,000 (-83.57%)

Accumulated Other Comprehensive Income

$35,000 (-84.30%)

$223,000 (113.18%)

-$1,692,000 (-137.97%)

-$711,000 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$121,140,000 (-41.66%)

$207,644,000 (21.34%)

$171,123,000 (-34.03%)

$259,405,000 (0%)

Investments Current

$121,140,000 (-41.66%)

$207,644,000 (21.34%)

$171,123,000 (-34.03%)

$259,405,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$7,732,000 (68.82%)

$4,580,000 (-32.42%)

$6,777,000 (-13.56%)

$7,840,000 (100.00%)

Accumulated Retained Earnings (Deficit)

-$583,563,000 (-27.86%)

-$456,390,000 (-36.42%)

-$334,558,000 (-52.68%)

-$219,120,000 (-103.97%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$18,025,000 (6.73%)

$16,888,000 (821.83%)

$1,832,000 (5.29%)

$1,740,000 (0%)

Debt Current

$2,700,000 (82.31%)

$1,481,000 (-19.16%)

$1,832,000 (5.29%)

$1,740,000 (0%)

Debt Non-Current

$15,325,000 (-0.53%)

$15,407,000 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$44,056,000 (8.58%)

$40,575,000 (61.89%)

$25,063,000 (30.53%)

$19,201,000 (68.33%)

Liabilities Current

$25,641,000 (17.46%)

$21,829,000 (0.59%)

$21,702,000 (13.03%)

$19,201,000 (68.80%)

Liabilities Non-Current

$18,415,000 (-1.77%)

$18,746,000 (457.75%)

$3,361,000 (0%)

$0 (0%)

PRLD Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$28,719,000 (-0.57%)

$28,884,000 (-5.76%)

$30,651,000 (13.70%)

$26,957,000 (154.65%)

Research & Development Expense

$117,995,000 (14.12%)

$103,393,000 (11.31%)

$92,889,000 (7.04%)

$86,778,000 (80.12%)

Operating Expenses

$146,714,000 (10.91%)

$132,277,000 (7.07%)

$123,540,000 (8.62%)

$113,735,000 (93.55%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$127,173,000 (-4.38%)

-$121,832,000 (-5.54%)

-$115,438,000 (-3.35%)

-$111,694,000 (-96.20%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$127,173,000 (-4.38%)

-$121,832,000 (-5.54%)

-$115,438,000 (-3.35%)

-$111,694,000 (-96.20%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$127,173,000 (-4.38%)

-$121,832,000 (-5.54%)

-$115,438,000 (-3.35%)

-$111,694,000 (-96.20%)

Weighted Average Shares

$75,805,840 (25.60%)

$60,357,052 (27.41%)

$47,371,589 (2.87%)

$46,049,763 (269.03%)

Weighted Average Shares Diluted

$75,805,840 (25.60%)

$60,357,052 (27.41%)

$47,371,589 (2.87%)

$46,049,763 (269.03%)

Earning Before Interest & Taxes (EBIT)

-$127,173,000 (-4.38%)

-$121,832,000 (-5.54%)

-$115,438,000 (-3.35%)

-$111,694,000 (-96.20%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$146,714,000 (-10.91%)

-$132,277,000 (-7.07%)

-$123,540,000 (-8.62%)

-$113,735,000 (-93.55%)

PRLD Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$90,191,000 (360.32%)

-$34,646,000 (-142.41%)

$81,691,000 (130.97%)

-$263,803,000 (-42380.35%)

Net Cash Flow from Financing

-$120,000 (-100.09%)

$136,395,000 (16635.58%)

$815,000 (-99.51%)

$164,897,000 (-33.03%)

Net Cash Flow from Operations

-$102,888,000 (3.90%)

-$107,063,000 (-27.87%)

-$83,729,000 (-0.24%)

-$83,531,000 (-80.89%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$12,817,000 (-141.19%)

-$5,314,000 (-334.51%)

-$1,223,000 (99.33%)

-$182,437,000 (-191.48%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$90,955,000 (392.15%)

-$31,133,000 (-136.75%)

$84,710,000 (132.40%)

-$261,480,000 (0%)

Capital Expenditure

-$764,000 (78.25%)

-$3,513,000 (-16.36%)

-$3,019,000 (-29.96%)

-$2,323,000 (-274.07%)

Issuance (Repayment) of Debt Securities

-$395,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$439,000 (-99.68%)

$136,412,000 (16637.67%)

$815,000 (-99.51%)

$165,200,000 (-0.92%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$21,345,000 (-16.67%)

$25,616,000 (1.88%)

$25,144,000 (20.13%)

$20,931,000 (274.91%)

Depreciation Amortization & Accretion

$3,363,000 (8.31%)

$3,105,000 (2.07%)

$3,042,000 (35.62%)

$2,243,000 (313.84%)

PRLD Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-74.70% (-39.89%)

-53.40% (-5.95%)

-50.40% (-45.24%)

-34.70% (50.36%)

Return on Average Assets (ROAA)

-60.30% (-25.63%)

-48.00% (-4.12%)

-46.10% (-39.70%)

-33.00% (28.88%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-69.20% (-22.05%)

-56.70% (9.86%)

-62.90% (30.42%)

-90.40% (-106.10%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.76 (64.10%)

-2.11 (14.59%)

-2.48 (51.69%)

-5.12 (67.35%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.53 (-45.90%)

0.99 (-33.27%)

1.48 (-28.06%)

2.06 (-86.05%)

Debt to Equity Ratio (D/E)

0.34 (95.91%)

0.17 (33.59%)

0.13 (91.04%)

0.07 (24.07%)

Earnings Per Share (EPS)

-1.68 (16.83%)

-2.02 (17.21%)

-2.44 (-0.41%)

-2.43 (46.71%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.37 (25.38%)

-1.83 (-0.05%)

-1.83 (1.77%)

-1.86 (50.29%)

Book Value Per Share (BVPS)

1.73 (-55.86%)

3.93 (-4.80%)

4.13 (-33.54%)

6.21 (-63.49%)

Tangible Assets Book Value Per Share (TABVPS)

2.31 (-49.67%)

4.6 (-1.18%)

4.66 (-29.74%)

6.63 (-63.03%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (50.00%)

-2 (0.00%)

-2 (60.00%)

-5 (90.20%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.59 (67.31%)

-1.81 (13.29%)

-2.08 (56.82%)

-4.83 (90.59%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

5.3 (-50.89%)

10.79 (14.59%)

9.42 (-38.72%)

15.37 (-20.82%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$103,652,000 (6.26%)

-$110,576,000 (-27.47%)

-$86,748,000 (-1.04%)

-$85,854,000 (-83.46%)

Enterprise Value (EV)

$73,127,842 (-65.93%)

$214,641,943 (-8.43%)

$234,395,271 (-55.65%)

$528,555,132 (-81.72%)

Earnings Before Tax (EBT)

-$127,173,000 (-4.38%)

-$121,832,000 (-5.54%)

-$115,438,000 (-3.35%)

-$111,694,000 (-96.20%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$123,810,000 (-4.28%)

-$118,727,000 (-5.63%)

-$112,396,000 (-2.69%)

-$109,451,000 (-94.11%)

Invested Capital

$151,381,000 (-37.80%)

$243,389,000 (46.64%)

$165,981,000 (-34.07%)

$251,765,000 (4231.36%)

Working Capital

$110,254,000 (-48.42%)

$213,760,000 (17.01%)

$182,678,000 (-33.79%)

$275,914,000 (31.74%)

Tangible Asset Value

$175,515,000 (-36.79%)

$277,665,000 (25.93%)

$220,500,000 (-27.73%)

$305,098,000 (36.45%)

Market Capitalization

$70,169,842 (-70.03%)

$234,106,943 (-19.01%)

$289,073,271 (-50.82%)

$587,831,132 (-81.20%)

Average Equity

$170,225,000 (-25.40%)

$228,176,000 (-0.31%)

$228,875,000 (-28.92%)

$322,016,750 (295.67%)

Average Assets

$211,033,000 (-16.84%)

$253,776,750 (1.25%)

$250,638,250 (-26.05%)

$338,931,750 (176.16%)

Invested Capital Average

$183,743,750 (-14.46%)

$214,803,500 (17.13%)

$183,389,750 (48.36%)

$123,608,500 (3319.39%)

Shares

55,035,170 (0.38%)

54,825,982 (14.56%)

47,859,813 (1.36%)

47,215,352 (8.04%)